| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |